| Literature DB >> 32286721 |
Lara A Ray1, Erica N Grodin1, Lorenzo Leggio2, Anita J Bechtholt3, Howard Becker4, Sarah W Feldstein Ewing5, James David Jentsch6, Andrea C King7, Barbara J Mason8, Stephanie O'Malley9, James MacKillop10, Markus Heilig11, George F Koob12.
Abstract
In March 2019, a scientific meeting was held at the University of California, Los Angeles (UCLA) Luskin Center to discuss approaches to expedite the translation of neurobiological insights to advances in the treatment of alcohol use disorder (AUD). A guiding theme that emerged was that while translational research in AUD is clearly a challenge, it is also a field ripe with opportunities. Herein, we seek to summarize and disseminate the recommendations for the future of translational AUD research using four sections. First, we briefly review the current landscape of AUD treatment including the available evidence-based treatments and their uptake in clinical settings. Second, we discuss AUD treatment development efforts from a translational science viewpoint. We review current hurdles to treatment development as well as opportunities for mechanism-informed treatment. Third, we consider models of translational science and public health impact. Together, these critical insights serve as the bases for a series of recommendations and future directions. Towards the goal of improving clinical care and population health for AUD, scientists are tasked with bolstering the clinical applicability of their research findings so as to expedite the translation of knowledge into patient care.Entities:
Keywords: AUD; medications; research; translational; treatment; treatment gap
Mesh:
Substances:
Year: 2020 PMID: 32286721 PMCID: PMC7554164 DOI: 10.1111/adb.12903
Source DB: PubMed Journal: Addict Biol ISSN: 1355-6215 Impact factor: 4.280